Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study : The Impact of Treatment and Other Baseline Factors

• Published in: Ophthalmology (Rochester, Minn.) Vol. 116; no. 2; pp. 200 - 207
• Main Authors: MUSCH, David C, GILLESPIE, Brenda W, LICHTER, Paul R, NIZIOL, Leslie M, JANZ, Nancy K
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier 01.02.2009
• Subjects: Adult; Aged; Aging - physiology; Antihypertensive Agents - therapeutic use; Biological and medical sciences; Disease Progression; Female; Follow-Up Studies; Glaucoma and intraocular pressure; Glaucoma, Open-Angle - drug therapy; Glaucoma, Open-Angle - physiopathology; Glaucoma, Open-Angle - surgery; Humans; Intraocular Pressure - physiology; Male; Medical sciences; Middle Aged; Miscellaneous; Ophthalmology; Risk Factors; Tonometry, Ocular; Trabeculectomy; Vision Disorders - physiopathology; Visual Acuity - physiology; Visual Field Tests; Visual Fields; Glaucoma; Protozoa; Eye disease; Prognosis; Treatment; Glaucoma (eye); Visual field; Evolution; Ciliata; Ophthalmology

To evaluate factors associated with visual field (VF) progression, using all available follow-up through 9 years after treatment initiation, in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Longitudinal follow-up of participants enrolled in a randomized clinical trial. Six hundred seve...